Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7006307

CC(C)Cl.CC(C)Cl.CC(C)Cl.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 1/20 0.35
CA13 Q8N1Q1 1/20 0.35
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
F2 P00734 2/20 0.31
PRSS1 P07477 2/20 0.31
PRSS2 P07478 2/20 0.31
PRSS3 P35030 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL30505750 0.97 ALDH1A1 (0.38) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL28900281 0.90 ALDH1A1 (0.41) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL23152606 0.88 ALDH1A1 (0.39) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL575705 0.88 ALDH1A1 (0.39) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL8817892 0.85 CA1 (0.40) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL27713140 0.85 ALDH1A1 (0.38) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL28243370 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL27964313 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL2290380 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7
Trifluoromethanesulfonic Acid SCHEMBL9460589 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268458-A1 CONVERSION OF 9-DIHYDRO-13-ACETYLBACCATIN III TO BACCATIN III AND 10-DEACETYLBACCATIN III Actipharm Inc. (CA) 2003-01-02 EP disclosed
US-20010041803-A1 Conversion of 9-dihydro-13-acetylbaccatin III to baccatin III and 10-deacetyl baccatin III ACTIPHARM, INC. (CA) 2001-11-15 US disclosed
WO-2001070717-A1 CONVERSION OF 9-DIHYDRO-13-ACETYLBACCATIN III TO BACCATIN III AND 10-DEACETYLBACCATIN III ACTIPHARM INC. (CA) 2001-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010041803-A1 Conversion of 9-dihydro-13-acetylbaccatin III to baccatin III and 10-deacetyl baccatin III TUBA3C, TUBB3, CIAPIN1 ALDH1A1 1345/4885L3MBTL1 3922/4885CA1 1613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.